Home/Filings/4/0001181431-07-008787
4//SEC Filing

OXIGENE INC 4

Accession 0001181431-07-008787

$OTLCCIK 0000908259operating

Filed

Feb 5, 7:00 PM ET

Accepted

Feb 6, 2:28 PM ET

Size

5.4 KB

Accession

0001181431-07-008787

Insider Transaction Report

Form 4
Period: 2007-01-25
CHAPLIN DAVID
Chief Scientific Officer
Transactions
  • Award

    Option to Purchase Common Stock

    2007-01-25+25,00025,000 total
    Exercise: $4.18From: 2008-01-25Exp: 2017-01-24Common Stock (25,000 underlying)
Footnotes (1)
  • [F1]The option shall vest in equal annual installments over four years beginning on the first anniversary of the grant.

Issuer

OXIGENE INC

CIK 0000908259

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0000908259

Filing Metadata

Form type
4
Filed
Feb 5, 7:00 PM ET
Accepted
Feb 6, 2:28 PM ET
Size
5.4 KB